DOI: 10.15490/fairdomhub.1.study.1070.1
Zenodo URL: None
Created at: 9th Dec 2022 at 15:52
Hematoxylin-Eosin (HE) staining
Stained sections were digitalized using a whole slide scanner (L11600, Hamamatsu, Ja-pan) equipped with the NDP.view2Plus Image viewing software (Version U12388-02).
* MNT-021_J-20-0152_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003 > Control
* MNT-022_J-20-0154_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003 > Control
* MNT-023_J-20-0156_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003 > Control
* MNT-024_J-20-0158_HE_LLL(green), RML(red), RSL (black),
...
Bl6J_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003
* MNT-021_J-20-0152_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003 > Control
* MNT-022_J-20-0154_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003 > Control
* MNT-023_J-20-0156_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003 > Control
* MNT-024_J-20-0158_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003 > Control
* MNT-025_J-20-0160_HE_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_003 > Control
* MNT-026_J-20-0162_HE_LLL(green), RML(red),
...
- 03. HE-Whole slide scans.zip
HE-Steatosis analysis: Steatosis Quantification
Steatosis Quantification (Lipid droplet analysis) report using Histokat, a proprietary software based on a machine-learning algorithm created by Fraunhofer MEVIS
- report.html
HE steatosis pattern analysis: Generic Classification 128
steatosis pattern analysis report using Histokat, a proprietary software based on a machine-learning algorithm created by Fraunhofer MEVIS
- report.html
Immunohistochemistry _ CYP3A4
No description specified
Bl6J_CYP3A4 1/2000_Run 10_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_005
* MNT-021_J-20-0152_CYP3A4 1/2000_Run 10_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_005 > Control
* MNT-022_J-20-0154_CYP3A4 1/2000_Run 10_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_005 > Control
* MNT-023_J-20-0156_CYP3A4 1/2000_Run 10_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_005 > Control
* MNT-024_J-20-0158_CYP3A4 1/2000_Run 10_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_005 > Control
* MNT-025_J-20-0160_CYP3A4 1/2000_Run 10_LLL(green), RML(red),
...
- 05. CYP3A4.zip
Immunohistochemistry _ CYP1A2
No description specified
Bl6J_CYP1A2-1 500_Run 08_LLL, RML, RSL, ICL_MAA_0002
* MNT-021_J-20-0152_Bl6J_CYP1A2-1/500_Run 08_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_002 > Control
* MNT-022_J-20-0154_Bl6J_CYP1A2-1/500_Run 08_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_002 > Control
* MNT-023_J-20-0156_Bl6J_CYP1A2-1/500_Run 08_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_002 > Control
* MNT-024_J-20-0158_Bl6J_CYP1A2-1/500_Run 08_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_002 > Control
* MNT-025_J-20-0160_Bl6J_CYP1A2-1/500_Run
...
Bl6J_CYP1A2-1 500_Run 08_LLL, RML, RSL, ICL_MAA_0002
* MNT-021_J-20-0152_Bl6J_CYP1A2-1/500_Run 08_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_002 > Control
* MNT-022_J-20-0154_Bl6J_CYP1A2-1/500_Run 08_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_002 > Control
* MNT-023_J-20-0156_Bl6J_CYP1A2-1/500_Run 08_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_002 > Control
* MNT-024_J-20-0158_Bl6J_CYP1A2-1/500_Run 08_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_002 > Control
* MNT-025_J-20-0160_Bl6J_CYP1A2-1/500_Run
...
- 02. CYP1A2.zip
Immunohistochemistry _ CYP2D6
No description specified
Mouse_Bl6J_J-20-0154_CYP2D6- 1 3000_Run 14_ML, RML, RSL, ICL_MAA_004
* MNT-021_Bl6J_J-20-0152_CYP2D6- 1/3000_Run 14_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_004 > Control
* MNT-022_Bl6J_J-20-0154_CYP2D6- 1/3000_Run 14_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_004 > Control
* MNT-023_Bl6J_J-20-0156_CYP2D6- 1/3000_Run 14_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_004 > Control
* MNT-024_Bl6J_J-20-0158_CYP2D6- 1/3000_Run 14_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_004 > Control
* MNT-025_Bl6J_J-20-0160_CYP2D6- 1/3000_Run
...
Mouse_Bl6J_J-20-0154_CYP2D6- 1 3000_Run 14_ML, RML, RSL, ICL_MAA_004
* MNT-021_Bl6J_J-20-0152_CYP2D6- 1/3000_Run 14_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_004 > Control
* MNT-022_Bl6J_J-20-0154_CYP2D6- 1/3000_Run 14_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_004 > Control
* MNT-023_Bl6J_J-20-0156_CYP2D6- 1/3000_Run 14_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_004 > Control
* MNT-024_Bl6J_J-20-0158_CYP2D6- 1/3000_Run 14_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_004 > Control
* MNT-025_Bl6J_J-20-0160_CYP2D6- 1/3000_Run
...
- 04. CYP2D.zip
Immunohistochemistry _ CYP2E1
No description specified
Bl6J_CYP2E1- 1 400_Run 11_LLL, RML, RSL, ICL_MAA_0006
* MNT-021_Bl6J_J-20-0152_CYP2E1- 1/400_Run 011_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_006 >Control
* MNT-022_Bl6J_J-20-0154_CYP2E1- 1/400_Run 011_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_006 >Control
* MNT-023_Bl6J_J-20-0156_CYP2E1- 1/400_Run 011_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_006 >Control
* MNT-024_Bl6J_J-20-0158_CYP2E1- 1/400_Run 011_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_006 >Control
* MNT-025_Bl6J_J-20-0160_CYP2E1- 1/400_Run
...
Bl6J_CYP2E1- 1 400_Run 11_LLL, RML, RSL, ICL_MAA_0006
* MNT-021_Bl6J_J-20-0152_CYP2E1- 1/400_Run 011_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_006 >Control
* MNT-022_Bl6J_J-20-0154_CYP2E1- 1/400_Run 011_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_006 >Control
* MNT-023_Bl6J_J-20-0156_CYP2E1- 1/400_Run 011_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_006 >Control
* MNT-024_Bl6J_J-20-0158_CYP2E1- 1/400_Run 011_LLL(green), RML(red), RSL (black), ICL(yellow)_MAA_006 >Control
* MNT-025_Bl6J_J-20-0160_CYP2E1- 1/400_Run
...
- 06. CYP2E1.zip
SteaPk-data Histology Quant., CYP activity, Protein, TG, AUC
No description specified
2022-12-08_ Histology Quant., CYP activity, Protein, TG, AUC
Raw data used for Steatosis and CYP quantification and TG, PK-data, AUC, t-halflife and C-max
- 2022-12-08_ Histology Quant., CYP activity, Protein, TG, AUC.xlsx
Animal experiment and Pharmacokinetics data
No description specified
2022-07-18_ Experimental data- Drug injection and Pharmacokinetics_Stea pk - documentation
Excel file involves all experiment data including feeding plan, sampling plan, and the Pharmacokinetic data results
- 2022-07-16_ Experimental data- Drug injection and Pharmacokinetics_Stea pk - documentation.xlsx
Bayesian uncertainty quantification
The experimental data of Midazolam, OH-Midazolam, Caffein, Codeine, Norcodeine, Codein-6Glucuronide, Morphine-3Glucuronide and Morphine was analyzed via a Bayesian uncertainty quantification. An underlying model describing the bolus injection, followed by the exponential decay was written in sbml and a PEtab problem was created. The sampling and ensemble creation was conducted with the python toolbox pyPESTO.
For further details, please take a look at the methods section of the paper.
Visualization of marginals, credibility intervals and ensemble output predictions
For each drug and condition, there is one:
* Visualization of the marginals and the sampling traces
* The credibility intervals for the parameters with the median
* Visualization of the individual ensemble output predictions with boxplots of the underlying data
Furthermore all conditions of the ensemble output predictions for one drug are visulized in one plot.
- Visualization.zip
Bayesian UQ for experimental data: Code
This code uses the PEtab problem (written in the yaml file) to perform MCMC sampling with pyPESTO. Afterwards an ensemble is created, that allows to compute the posterior predictive distribution and therefore the credibility intervals for the model output.
The sampling.py scipt of pyPESTO visulize was adjusted for an improved visualization. The used code was also uploaded.
A Conda environment file (.yml) containing the specific version of Python and installed packages with the according versions,
...
- Bayesian UQ for experimental data code.zip
Posterior distributions
Complete posterior distributions for each drug and condition.
The files are in the hdf5 format and contain the complete information of the analysis for a FAIR data sharing.
- Posterior.zip
AUC values and parameters of the corresponding curves for each replicate of each drug and condition
The parameters A and B were estimated for the function f(x)=x⋅e^(B-Ax) and the AUC was calculated for the decay phase only. For OH-Midazolam the fourth replicate in the 2 weeks condition has an outlier in the measurement after six hours (more than 2SD above the mean of this condition) and was omitted for the AUC calculation as this could not be fitted to an exponential decay.
- AUC values.zip
Exponential Decay PEtab Problem in yaml format
The exponential decay model with all parameters, observables and conditions was specified in a yaml file.
This yaml file is converted with yaml2sbml (2020 Jakob Vanhoefer, Marta R. A. Matos, Dilan Pathirana, Yannik Schaelte and Jan Hasenauer) to a PEtab problem, which contains also the SBML model.
- Exponential_decay_model.yaml
Compiled SBML models from PEtab yaml file
The SOP creates a separate SBML model for each drug and condition, as the PEtab problem contains diffrent experimental data for them.
However, the SBML models only differ in their name as for all drugs and conditions, the same exponential decay model was assumed.
The SBMLs are automatically created by yaml2sbml, when the SOP is executed. Therefore, these files are for completeness only and are not necessary to replicate the analysis.
- SBML models.zip
These checksums allow you to check a Snapshot you have downloaded hasn't been modified. For details on how to use these please visit this guide
MD5: ad4b52d0d7e4b3fe729ced9f10c379f6
SHA1: abfd84922dcc1f78a278959e449d04c1371714fb
Views: 807 Downloads: 62
Created: 9th Dec 2022 at 15:52
Last updated: 9th Dec 2022 at 17:10